Hims & Hers Health Cost of Goods Sold 2020-2025 | HIMS
Hims & Hers Health annual/quarterly cost of goods sold history and growth rate from 2020 to 2025. Cost of goods sold can be defined as the difference between beginning and ending inventories for tangible products resulting in an expense that reflects production and sales costs.
- Hims & Hers Health cost of goods sold for the quarter ending March 31, 2025 was $0.155B, a 216.49% increase year-over-year.
- Hims & Hers Health cost of goods sold for the twelve months ending March 31, 2025 was $0.410B, a 142.69% increase year-over-year.
- Hims & Hers Health annual cost of goods sold for 2024 was $0.303B, a 93.17% increase from 2023.
- Hims & Hers Health annual cost of goods sold for 2023 was $0.157B, a 32.88% increase from 2022.
- Hims & Hers Health annual cost of goods sold for 2022 was $0.118B, a 75.4% increase from 2021.
| Hims & Hers Health Annual Cost of Goods Sold (Millions of US $) |
|
|---|---|
| 2024 | $303 |
| 2023 | $157 |
| 2022 | $118 |
| 2021 | $67 |
| 2020 | $39 |
| 2019 | $38 |
| 2018 | $0 |
| Hims & Hers Health Quarterly Cost of Goods Sold (Millions of US $) |
|
|---|---|
| 2025-03-31 | $155 |
| 2024-12-31 | $112 |
| 2024-09-30 | $84 |
| 2024-06-30 | $59 |
| 2024-03-31 | $49 |
| 2023-12-31 | $43 |
| 2023-09-30 | $39 |
| 2023-06-30 | $38 |
| 2023-03-31 | $37 |
| 2022-12-31 | $35 |
| 2022-09-30 | $30 |
| 2022-06-30 | $26 |
| 2022-03-31 | $27 |
| 2021-12-31 | $23 |
| 2021-09-30 | $19 |
| 2021-06-30 | $13 |
| 2021-03-31 | $12 |
| 2020-12-31 | $10 |
| 2020-09-30 | $10 |
| 2020-06-30 | $10 |
| 2020-03-31 | $9 |
| 2019-12-31 | |
| 2019-09-30 | |
| 2019-06-30 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $14.374B | $1.477B |
| Hims & Hers Health Inc. is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling medical care for numerous conditions related to mental health, sexual health, dermatology, primary care and more. Hims & Hers Health Inc., formerly known as Oaktree Acquisition Corp., is based in San Francisco. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $45.768B | 58.23 |
| Tempus AI (TEM) | United States | $11.826B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.653B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.861B | 60.33 |
| Hinge Health (HNGE) | United States | $3.282B | 0.00 |
| Privia Health (PRVA) | United States | $2.664B | 182.08 |
| Enovis (ENOV) | United States | $1.720B | 9.59 |
| Phreesia (PHR) | United States | $1.560B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.537B | 0.00 |
| Schrodinger (SDGR) | United States | $1.501B | 0.00 |
| Azenta (AZTA) | United States | $1.357B | 63.06 |
| 10x Genomics (TXG) | United States | $1.331B | 0.00 |
| Omnicell (OMCL) | United States | $1.313B | 23.17 |
| Claritev (CTEV) | United States | $0.657B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.595B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.514B | 0.00 |
| Veradigm (MDRX) | United States | $0.487B | 0.00 |
| Talkspace (TALK) | United States | $0.448B | 134.00 |
| Standard BioTools (LAB) | United States | $0.399B | 0.00 |
| TruBridge (TBRG) | United States | $0.337B | 746.67 |
| Outset Medical (OM) | United States | $0.336B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.263B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.251B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.203B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.156B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.138B | 0.00 |
| CareCloud (CCLD) | United States | $0.106B | 4.03 |
| Pulmonx (LUNG) | United States | $0.105B | 0.00 |
| American Well (AMWL) | United States | $0.105B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.094B | 0.00 |
| 111 (YI) | China | $0.069B | 0.00 |
| HeartBeam (BEAT) | United States | $0.051B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.046B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.045B | 0.00 |
| Zhongchao (ZCMD) | China | $0.037B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.035B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Precipio (PRPO) | United States | $0.017B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.016B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.010B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.003B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.001B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |